In patients receiving percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), post-conditioning therapy reduces infarct size and edema by one-third compared ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- ...
TRX®, the global leader in functional training, and BlazePod®, the pioneer of light-based reaction training, today announced ...
CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) and Forty Seven, Inc. (Nasdaq:FTSV) announced today that they have entered into a research collaboration to ...
Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of acute kidney injury (AKI). It will be the ...